Literature DB >> 15361954

[Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services].

Jackeline Gomes Guerra1, Gerson Oliveira Penna, Lia Cândida Miranda de Castro, Celina Maria Turchi Martelli, Mariane Martins Araújo Stefani, Maurício Barcelos Costa.   

Abstract

Erythema nodosum leprosum is an acute inflammatory event in the chronic course of leprosy. It is considered an immunological disorder and an important cause of morbidity and disability. We evaluate the clinical profile, serology and histopathology 58 erythema nodosum leprosum patients sequentially recruited, from July- December 2000, in an endemic area in Central Brazil (Goiás State). Half of the reactins were considered severe and 66% of the cases had the first episode of reaction during specific treatment. The majority of patients and controls were positive to anti-PGL-I IgM. The more frequent histopathological findings in erythema nodosum leprosum were presence of intracellular acid-fast bacilli, perivascular/peradnexial mononuclear inflammatory infiltrate, and neural aggression. Ninety six percent of the patients were treated with systemic steroid in the first episode. The results point out to the association between ENL and neuritis and the rare adoption of thalidomide as a solely medication in the health services.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361954     DOI: 10.1590/s0037-86822004000500003

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

1.  Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.

Authors:  Fátima Regina Vilani-Moreno; Vânia Nieto Brito-de-Souza; Sônia Maria Usó Ruiz Silva; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Ana Paula Campanelli; Jaison Antonio Barreto; Marcos da Cunha Lopes Virmond
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

2.  Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy.

Authors:  Luciana Silva Rodrigues; Mariana Andrea Hacker; Ximena Illarramendi; Maria Fernanda Miguens Castelar Pinheiro; José Augusto da Costa Nery; Euzenir Nunes Sarno; Maria Cristina Vidal Pessolani
Journal:  BMC Infect Dis       Date:  2011-12-13       Impact factor: 3.090

3.  Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.

Authors:  Emerith Mayra Hungria; Regiane Morillas Oliveira; Gerson Oliveira Penna; Lúcio Cartaxo Aderaldo; Maria Araci de Andrade Pontes; Rossilene Cruz; Heitor de Sá Gonçalves; Maria Lúcia Fernandes Penna; Ligia Regina Franco Sansigolo Kerr; Mariane Martins de Araújo Stefani; Samira Bührer-Sékula
Journal:  Infect Dis Poverty       Date:  2016-12-06       Impact factor: 4.520

4.  Evaluation of Polymorphisms in Toll-Like Receptor Genes as Biomarkers of the Response to Treatment of Erythema Nodosum Leprosum.

Authors:  Miriãn Ferrão Maciel-Fiuza; Perpétua do Socorro Silva Costa; Thayne Woycinck Kowalski; Lavínia Schuler-Faccini; Renan Rangel Bonamigo; Rodrigo Vetoratto; Letícia Maria Eidt; Paulo Cezar de Moraes; Maria Irismar da Silva Silveira; Luis Marcelo Aranha Camargo; Sidia Maria Callegari-Jacques; Stela Maris de Jezus Castro; Fernanda Sales Luiz Vianna
Journal:  Front Med (Lausanne)       Date:  2022-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.